ROTIROTI, MARIA CATERINA
ROTIROTI, MARIA CATERINA
DIPARTIMENTO DI MEDICINA E CHIRURGIA (SCHOOL OF MEDICINE AND SURGERY)
Balance of Anti-CD123 Chimeric Antigen Receptor Binding Affinity and Density for the Targeting of Acute Myeloid Leukemia
2017 Arcangeli, S; Rotiroti, M; Bardelli, M; Simonelli, L; Magnani, C; Biondi, A; Biagi, E; Tettamanti, S; Varani, L
Acute Myeloid Leukemia Targeting by Chimeric Antigen Receptor T Cells: Bridging the Gap from Preclinical Modeling to Human Studies
2017 Rotiroti, M; Arcangeli, S; Casucci, M; Perriello, V; Bondanza, A; Biondi, A; Tettamanti, S; Biagi, E
Characterization of Chimeric Antigen Receptors (CARs) as a potential tool for the treatment of Acute Myeloid Leukemia (AML)
2019 Rotiroti, M
Targeting CD33 in Chemoresistant AML Patient-Derived Xenografts by CAR-CIK Cells Modified with an Improved SB Transposon System
2020 Rotiroti, M; Buracchi, C; Arcangeli, S; Galimberti, S; Valsecchi, M; Perriello, V; Rasko, T; Alberti, G; Magnani, C; Cappuzzello, C; Lundberg, F; Pande, A; Dastoli, G; Introna, M; Serafini, M; Biagi, E; Izsvák, Z; Biondi, A; Tettamanti, S
Optimization of therapeutic T cell expansion in G-Rex device and applicability to large-scale production for clinical use
2022 Gotti, E; Tettamanti, S; Zaninelli, S; Cuofano, C; Cattaneo, I; Rotiroti, M; Cribioli, S; Alzani, R; Rambaldi, A; Introna, M; Golay, J
IL3-zetakine combined with a CD33 costimulatory receptor as a Dual CAR approach for safer and selective targeting of AML
2023 Perriello, V; Rotiroti, M; Pisani, I; Galimberti, S; Alberti, G; Pianigiani, G; Ciaurro, V; Marra, A; Sabino, M; Tini, V; Spinozzi, G; Mezzasoma, F; Morena, F; Martino, S; Salerno, D; Ashby, J; Wingham, B; Serafini, M; Martelli, M; Falini, B; Biondi, A; Tettamanti, S